Sun exposure is the primary risk factor for amelanotic melanoma
The first readout, TRIUMPH-1 (obesity), was reported on 21 May 2026, with 28.3% mean weight loss at 80 weeks in the 12mg cohort (Pharmaceutical Journal)
The researchers emphasize that weight loss associated with GLP-1 drugs has many clear health benefits for people with obesity, type 2 diabetes and heart failure, including improving blood-sugar control, short-term cardiorenal benefits and improvements in survival outcomes
The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimers disease
This article examines the compatibility of semaglutide and thyroid medication, addressing FDA warnings, monitoring requirements, and practical considerations for patients taking both therapies concurrently
Rest, Recovery, and Stress Management Ample rest, recovery, and stress management play a crucial role in supporting muscle growth